MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-08-0000102
Market Cap
₹71.99 Cr
SUNLOC · NSE
Share Price
₹73.90
+5.27% today
Revenue
₹87.72 Cr
FY 2025-26 · +5.2% YoY
EBITDA
₹12.65 Cr
Margin 14.4%
Net Profit
₹4.10 Cr
FY 2025-26 · +410.6% YoY
P/E (TTM)
19.6x
P/B 1.4x
Authorised capital
₹17 Cr
Registered with MCA
Paid-up capital
₹16.08 Cr
Issued & subscribed
About Sunil Healthcare Limited
Data last updated:
Sunil Healthcare Limited is a public limited company based in New Delhi, Delhi, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 05 February 1973 and has been in existence for over 53 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L24302DL1973PLC189662. Its GSTIN is 07AACCS9198Q1ZA (Delhi). The company holds 3 GST registrations, of which 2 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 537253 and NSE: SUNLOC.
The company has an authorised share capital of ₹17 Cr and a paid-up capital of ₹16.08 Cr. It was formerly known as Sunil Synchem Limited. It is led by directors including Anil Kumar Khaitan (Managing Director) and Bejon Kumar Misra.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 38E/252A Vijay Tower Shahpurjat, New Delhi, Delhi, India – 110049.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹87.72 Cr, a growth of 5.2% compared to the previous year. For the same year it recorded a net profit of ₹4.1 Cr (net margin 4.7%) and EBITDA of ₹12.65 Cr (EBITDA margin 14.4%). The net worth stands at ₹71.38 Cr (up 4.1% YoY). Total assets are valued at ₹133 Cr (down 3.1% YoY).
The company has about 202 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sunil Healthcare. As per MCA filings, the company has open charges of ₹80.27 Cr and satisfied charges of ₹101.82 Cr on record. Court records list 103 cases involving the company, including 58 filed by the company and 45 filed against it; 25 cases are pending. The company has 3 deals on record (3 market trades); the latest was in May 2024. Its 4 peer companies in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Angstrom Biotech Private Limited with revenue of ₹86.9 Cr.
Sunil Healthcare Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0000102). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunilhealthcare.com.
Company details
CIN L24302DL1973PLC189662
Registration Number 189662
Incorporation Date 05 February 1973
ROC Delhi
Listing Status Listed - Listed on NSE (SUNLOC); Listed on BSE (537253)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-08-0000102
CIN history
Sunil Healthcare has one previous CIN (Corporate Identification Number): L24302RJ1973PLC001478. The current CIN is L24302DL1973PLC189662, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24302DL1973PLC189662 | Current |
| L24302RJ1973PLC001478 | Previous |
Recognitions & Rankings of Sunil Healthcare
Contact details
Sunil Healthcare Limited's registered office is in New Delhi, Delhi. Its website is sunilhealthcare.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address38E/252A Vijay Tower Shahpurjat, New Delhi, Delhi, India – 110049
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Sunil Healthcare Limited, buy the company report.
Comprehensive company report
Sunil Healthcare Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sunil Healthcare operates one associated brand: Sunil Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Quality assurance and regulatory services for biopharma sector are provided. | sunilhealthcare.com |
Business activity
The main business activity of Sunil Healthcare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sunil Healthcare Limited, buy the company report.
Financials of Sunil Healthcare Limited
FY 2025-26 filings availableSunil Healthcare Limited reported revenue of ₹87.72 Cr (up 5.2% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹87.72 Cr
+5.2% YoY
EBITDA
₹12.65 Cr
+23.4% YoY
Profit After Tax
₹4.10 Cr
+410.6% YoY
Net Worth
₹71.38 Cr
+4.1% YoY
Total Assets
₹133 Cr
-3.1% YoY
Total Debt
₹57.60 Cr
-14.2% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 87.72 | 83.42 | 90.19 | 110 | 119 | 90.62 | 70.02 |
| Revenue growth | +5.2% | -7.5% | -18.4% | -7.3% | +31.5% | +29.4% | - |
| EBITDA | 12.65 | 10.25 | 4.07 | 16.17 | 17.38 | 5.29 | (7.20) |
| EBITDA margin | +14.4% | +12.3% | +4.5% | +14.6% | +14.6% | +5.8% | -10.3% |
| Profit before tax | 2.23 | (1.22) | (2.58) | 9.49 | 9.26 | (0.55) | (5.60) |
| Net profit | 4.10 | (1.32) | (1.64) | 6.62 | 6.38 | (0.60) | (4.70) |
| Net profit margin | +4.7% | -1.6% | -1.8% | +6.0% | +5.4% | -0.7% | -6.7% |
| EPS (₹) | 3.91 | (1.38) | (1.74) | 6.52 | 6.26 | (0.62) | (4.84) |
| Balance sheet | |||||||
| Total assets | 133 | 137 | 136 | 94.39 | 86.71 | 95.64 | 95.87 |
| Net worth | 71.38 | 68.60 | 69.55 | 57.15 | 50.96 | 44.59 | 45.35 |
| Total debt | 57.60 | 67.11 | 64.82 | 35.63 | 33.68 | 48.95 | 48.69 |
| Cash & bank | 2.33 | 3.09 | 3.61 | 3.94 | 3.46 | 8.28 | 5.00 |
| Net working capital | 51.39 | 51.75 | 51.07 | 29.61 | 18.64 | 29.14 | 30.21 |
| Cash flow | |||||||
| Cash from operations | 22.15 | 11.52 | (15.40) | 7.47 | 22.51 | 16.99 | 4.31 |
| Cash from investing | (2.85) | (7.70) | (10.11) | (3.40) | (4.24) | (11.36) | (2.52) |
| Cash from financing | (19.26) | (3.87) | 25.00 | (3.75) | (18.56) | (6.42) | (1.56) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.99 | 19.72 | 21.84 | 23.52 | 22.64 | 21.20 | 20.46 | 20.26 |
| Revenue growth (YoY) | -16.1% | -7.0% | +6.7% | +16.1% | +5.3% | - | - | - |
| Other income | 0.23 | 0.41 | 0.50 | 0.42 | 0.86 | 0.49 | 0.53 | 0.18 |
| EBITDA | 2.93 | 1.82 | 3.62 | 3.92 | 3.28 | 3.03 | 2.70 | 2.32 |
| EBITDA margin | +15.4% | +9.2% | +16.6% | +16.7% | +14.5% | +14.3% | +13.2% | +11.5% |
| Depreciation | 1.46 | 1.52 | 1.62 | 1.64 | 1.66 | 1.68 | 1.69 | 1.51 |
| Interest | 1.50 | 1.66 | 1.66 | 1.40 | 1.44 | 1.56 | 1.89 | 1.50 |
| Profit before tax | 0.20 | (0.95) | 0.84 | 1.30 | 1.04 | 0.28 | (0.35) | (0.51) |
| Tax | (0.26) | (2.46) | 0.26 | 0.31 | 0.12 | (0.08) | 0.20 | 0.04 |
| Net profit | 0.46 | 1.51 | 0.58 | 0.99 | 0.92 | 0.36 | (0.55) | (0.55) |
| EPS (₹) | 0.45 | 0.57 | 0.57 | 0.97 | 0.89 | 0.35 | (0.53) | (0.53) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 87.72 | 83.42 | 89.69 | 112 | 116 | 89.89 | 70.13 |
| Revenue growth | +5.2% | -7.0% | -19.8% | -3.9% | +29.5% | +28.2% | - |
| EBITDA | 4.38 | 11.85 | 4.27 | 19.30 | 17.81 | 6.15 | (6.72) |
| EBITDA margin | +5.0% | +14.2% | +4.8% | +17.3% | +15.3% | +6.8% | -9.6% |
| Profit before tax | (7.08) | 0.39 | (2.89) | 9.75 | 9.56 | 0.35 | (4.82) |
| Net profit | 3.88 | 0.27 | (1.94) | 6.90 | 6.73 | 0.31 | (3.90) |
| Net profit margin | +4.4% | +0.3% | -2.2% | +6.2% | +5.8% | +0.3% | -5.6% |
| EPS (₹) | (5.17) | 0.20 | (2.06) | 6.80 | 6.61 | 0.27 | (4.06) |
| Balance sheet | |||||||
| Total assets | 128 | 144 | 141 | 100 | 91.55 | 100 | 99.04 |
| Net worth | 69.61 | 75.19 | 75.38 | 62.88 | 55.79 | 48.95 | 48.53 |
| Total debt | 54.01 | 67.11 | 64.82 | 35.63 | 33.68 | 48.95 | 48.69 |
| Cash & bank | 2.32 | 3.08 | 3.59 | 3.37 | 3.23 | 7.77 | 4.83 |
| Net working capital | 46.05 | 58.35 | 56.92 | 35.35 | 23.35 | 33.37 | 33.25 |
| Cash flow | |||||||
| Cash from operations | 22.15 | 11.54 | (14.35) | 7.13 | 21.89 | 16.63 | 4.18 |
| Cash from investing | (2.85) | (7.70) | (10.62) | (3.40) | (3.35) | (11.33) | (2.46) |
| Cash from financing | (19.26) | (3.87) | 25.00 | (3.75) | (18.56) | (6.42) | (1.54) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.99 | 19.72 | 21.84 | 23.52 | 22.64 | 21.20 | 20.46 | 20.26 |
| Revenue growth (YoY) | -16.1% | -7.0% | +6.7% | +16.1% | +5.3% | - | - | - |
| Other income | 0.23 | 0.35 | 0.35 | 0.21 | 0.23 | 0.50 | 0.55 | 0.19 |
| Total expenses | 16.01 | 26.17 | 18.21 | 19.59 | 19.36 | 18.30 | 17.33 | 17.38 |
| EBITDA | 2.98 | (6.45) | 3.63 | 3.93 | 3.28 | 2.90 | 3.13 | 2.88 |
| EBITDA margin | +15.7% | -32.7% | +16.6% | +16.7% | +14.5% | +13.7% | +15.3% | +14.2% |
| Depreciation | 1.46 | 1.52 | 1.62 | 1.64 | 1.66 | 1.68 | 1.69 | 1.51 |
| Interest | 1.50 | 1.66 | 1.66 | 1.40 | 1.44 | 1.56 | 1.89 | 1.50 |
| Profit before tax | 0.25 | (9.28) | 0.70 | 1.10 | 0.41 | 0.16 | 0.10 | 0.06 |
| Tax | (0.26) | (2.46) | 0.26 | 0.31 | 0.12 | (0.08) | 0.20 | 0.04 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 11 Nov 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.99 | 19.72 | 21.84 | 23.52 | 22.64 | 21.20 | 20.46 | 20.26 |
| Revenue growth (YoY) | -16.1% | -7.0% | +6.7% | +16.1% | +5.3% | - | - | - |
| Other income | 0.23 | 0.41 | 0.50 | 0.42 | 0.86 | 0.49 | 0.53 | 0.18 |
| EBITDA | 2.93 | 1.82 | 3.62 | 3.92 | 3.28 | 3.03 | 2.70 | 2.32 |
| EBITDA margin | +15.4% | +9.2% | +16.6% | +16.7% | +14.5% | +14.3% | +13.2% | +11.5% |
| Depreciation | 1.46 | 1.52 | 1.62 | 1.64 | 1.66 | 1.68 | 1.69 | 1.51 |
| Interest | 1.50 | 1.66 | 1.66 | 1.40 | 1.44 | 1.56 | 1.89 | 1.50 |
| Profit before tax | 0.20 | (0.95) | 0.84 | 1.30 | 1.04 | 0.28 | (0.35) | (0.51) |
| Tax | (0.26) | (2.46) | 0.26 | 0.31 | 0.12 | (0.08) | 0.20 | 0.04 |
| Net profit | 0.46 | 1.51 | 0.58 | 0.99 | 0.92 | 0.36 | (0.55) | (0.55) |
| EPS (₹) | 0.45 | 0.57 | 0.57 | 0.97 | 0.89 | 0.35 | (0.53) | (0.53) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 87.72 | 83.42 | 90.19 | 110 | 119 | 90.62 | 70.02 |
| Revenue growth | +5.2% | -7.5% | -18.4% | -7.3% | +31.5% | +29.4% | - |
| Other income | 2.18 | 1.34 | 5.22 | 4.50 | 1.68 | 5.58 | 14.68 |
| Total expenses | 75.07 | 73.17 | 86.12 | 94.32 | 102 | 85.33 | 77.22 |
| Employee cost | 0.00 | 12.08 | 13.06 | 14.79 | 14.25 | 12.30 | 13.02 |
| EBITDA | 12.65 | 10.25 | 4.07 | 16.17 | 17.38 | 5.29 | (7.20) |
| EBITDA margin | +14.4% | +12.3% | +4.5% | +14.6% | +14.6% | +5.8% | -10.3% |
| Depreciation | 6.44 | 6.35 | 6.09 | 7.01 | 6.31 | 6.11 | 6.13 |
| Interest | 6.16 | 6.46 | 5.78 | 4.17 | 3.49 | 5.31 | 6.95 |
| Profit before tax | 2.23 | (1.22) | (2.58) | 9.49 | 9.26 | (0.55) | (5.60) |
| Tax | (1.77) | 0.20 | (0.77) | 2.80 | 2.84 | 0.09 | (0.63) |
| Net profit | 4.10 | (1.32) | (1.64) | 6.62 | 6.38 | (0.60) | (4.70) |
| Net profit margin | +4.7% | -1.6% | -1.8% | +6.0% | +5.4% | -0.7% | -6.7% |
| EPS (₹) | 3.91 | (1.38) | (1.74) | 6.52 | 6.26 | (0.62) | (4.84) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 12.03 | 11.79 | 11.59 | 11.41 | 11.26 | 11.13 | 11.01 |
| Reserves & surplus | 59.35 | 56.81 | 57.96 | 45.74 | 39.70 | 33.46 | 34.34 |
| Shareholders' funds (net worth) | 71.38 | 68.60 | 69.55 | 57.15 | 50.96 | 44.59 | 45.35 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 43.49 | 56.19 | 55.91 | 32.14 | 29.59 | 40.51 | 35.18 |
| Unsecured loans | 14.11 | 10.92 | 8.91 | 3.49 | 4.09 | 8.44 | 13.51 |
| Total debt | 57.60 | 67.11 | 64.82 | 35.63 | 33.68 | 48.95 | 48.69 |
| Total liabilities | 133 | 137 | 136 | 94.39 | 86.71 | 95.64 | 95.87 |
| Assets | |||||||
| Gross block | 138 | 142 | 129 | 108 | 103 | 96.36 | 90.67 |
| Net block | 85.85 | 94.08 | 87.16 | 70.43 | 69.97 | 69.80 | 69.97 |
| Capital work in progress | 1.77 | 0.09 | 5.66 | 0.01 | 1.75 | 0.01 | 0.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 1.07 | 0.11 |
| Inventories | 18.74 | 17.64 | 14.05 | 13.60 | 11.05 | 13.73 | 24.86 |
| Sundry debtors | 45.13 | 41.64 | 40.59 | 28.41 | 18.89 | 23.43 | 23.56 |
| Cash & bank balances | 2.33 | 3.09 | 3.61 | 3.94 | 3.46 | 8.28 | 5.00 |
| Loans & advances | 7.66 | 2.74 | 4.23 | 2.16 | 1.40 | 3.07 | 5.63 |
| Total current assets | 73.86 | 65.11 | 62.48 | 48.11 | 34.80 | 48.51 | 59.05 |
| Total current liabilities | 22.47 | 13.36 | 11.41 | 18.50 | 16.16 | 19.37 | 28.84 |
| Net working capital | 51.39 | 51.75 | 51.07 | 29.61 | 18.64 | 29.14 | 30.21 |
| Total assets | 133 | 137 | 136 | 94.39 | 86.71 | 95.64 | 95.87 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.03 | 0.08 | 0.59 | 0.27 | 0.55 | 1.34 | 1.11 |
| Net cash from operating activities | 22.15 | 11.52 | (15.40) | 7.47 | 22.51 | 16.99 | 4.31 |
| Net cash from investing activities | (2.85) | (7.70) | (10.11) | (3.40) | (4.24) | (11.36) | (2.52) |
| Net cash from financing activities | (19.26) | (3.87) | 25.00 | (3.75) | (18.56) | (6.42) | (1.56) |
| Net change in cash | 0.04 | (0.05) | (0.51) | 0.32 | (0.29) | (0.79) | 0.23 |
| Closing cash | 2.33 | 3.09 | 3.61 | 3.94 | 3.46 | 8.28 | 5.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.2% | -7.5% | -18.4% | -7.3% | +31.5% | +29.4% | - |
| EBITDA growth | +23.4% | +151.8% | -74.8% | -7.0% | +228.5% | +173.5% | - |
| PBT growth | +9998.0% | +52.7% | - | +2.5% | +9998.0% | +90.2% | -551.2% |
| Net income growth | +410.6% | +19.5% | -124.8% | +3.8% | +1163.3% | +87.2% | - |
| Revenue CAGR (3Y) | -7.4% | -11.2% | -0.2% | +16.4% | +13.8% | -0.4% | -13.6% |
| EBITDA CAGR (3Y) | -7.9% | -16.1% | -8.4% | - | +15.5% | -27.6% | - |
| Profitability & leverage | |||||||
| Net income margin | +4.6% | -1.7% | -2.0% | +6.1% | +5.4% | -0.7% | -7.1% |
| Return on capital employed | - | +4.4% | +3.1% | +15.6% | +14.5% | +5.0% | +1.4% |
| Return on net worth | - | -2.8% | -3.4% | +13.4% | +14.6% | -1.5% | -10.9% |
| Debt / equity | - | 1.27 | 0.94 | 0.68 | 0.92 | 1.12 | 1.13 |
| Long-term debt / equity | - | 0.35 | 0.26 | 0.18 | 0.28 | 0.31 | 0.23 |
| Interest cover | 99.19 | 165.64 | -286.14 | 45.52 | 31.53 | -647.56 | -52.14 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.70 | 0.83 | 1.08 | 1.23 | 0.98 | 0.80 |
| Inventory turnover | - | 5.26 | 6.52 | 8.96 | 9.62 | 4.70 | 3.38 |
| Debtors turnover | - | 2.03 | 2.61 | 4.67 | 5.63 | 3.86 | 2.23 |
| EPS (₹) | 3.91 | (1.38) | (1.74) | 6.52 | 6.26 | (0.62) | (4.84) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 49.09 | 49.71 | 51.73 | 45.84 | 39.76 | 43.58 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.99 | 19.72 | 21.84 | 23.52 | 22.64 | 21.20 | 20.46 | 20.26 |
| Revenue growth (YoY) | -16.1% | -7.0% | +6.7% | +16.1% | +5.3% | - | - | - |
| Other income | 0.23 | 0.35 | 0.35 | 0.21 | 0.23 | 0.50 | 0.55 | 0.19 |
| Total expenses | 16.01 | 26.17 | 18.21 | 19.59 | 19.36 | 18.30 | 17.33 | 17.38 |
| EBITDA | 2.98 | (6.45) | 3.63 | 3.93 | 3.28 | 2.90 | 3.13 | 2.88 |
| EBITDA margin | +15.7% | -32.7% | +16.6% | +16.7% | +14.5% | +13.7% | +15.3% | +14.2% |
| Depreciation | 1.46 | 1.52 | 1.62 | 1.64 | 1.66 | 1.68 | 1.69 | 1.51 |
| Interest | 1.50 | 1.66 | 1.66 | 1.40 | 1.44 | 1.56 | 1.89 | 1.50 |
| Profit before tax | 0.25 | (9.28) | 0.70 | 1.10 | 0.41 | 0.16 | 0.10 | 0.06 |
| Tax | (0.26) | (2.46) | 0.26 | 0.31 | 0.12 | (0.08) | 0.20 | 0.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 87.72 | 83.42 | 89.69 | 112 | 116 | 89.89 | 70.13 |
| Revenue growth | +5.2% | -7.0% | -19.8% | -3.9% | +29.5% | +28.2% | - |
| Other income | 1.14 | 1.35 | 4.70 | 1.63 | 1.55 | 5.62 | 14.98 |
| Total expenses | 83.34 | 71.57 | 85.42 | 92.53 | 98.56 | 83.74 | 76.85 |
| Employee cost | 0.00 | 12.08 | 13.06 | 14.79 | 14.25 | 12.30 | 13.02 |
| EBITDA | 4.38 | 11.85 | 4.27 | 19.30 | 17.81 | 6.15 | (6.72) |
| EBITDA margin | +5.0% | +14.2% | +4.8% | +17.3% | +15.3% | +6.8% | -9.6% |
| Depreciation | 6.44 | 6.35 | 6.08 | 7.01 | 6.31 | 6.11 | 6.13 |
| Interest | 6.16 | 6.46 | 5.78 | 4.17 | 3.49 | 5.31 | 6.95 |
| Profit before tax | (7.08) | 0.39 | (2.89) | 9.75 | 9.56 | 0.35 | (4.82) |
| Tax | (1.77) | 0.20 | (0.78) | 2.78 | 2.79 | 0.08 | (0.65) |
| Net profit | 3.88 | 0.27 | (1.94) | 6.90 | 6.73 | 0.31 | (3.90) |
| Net profit margin | +4.4% | +0.3% | -2.2% | +6.2% | +5.8% | +0.3% | -5.6% |
| EPS (₹) | (5.17) | 0.20 | (2.06) | 6.80 | 6.61 | 0.27 | (4.06) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 12.03 | 11.79 | 11.59 | 11.41 | 11.26 | 11.13 | 11.01 |
| Reserves & surplus | 57.58 | 63.40 | 63.79 | 51.47 | 44.53 | 37.82 | 37.52 |
| Shareholders' funds (net worth) | 69.61 | 75.19 | 75.38 | 62.88 | 55.79 | 48.95 | 48.53 |
| Secured loans | 43.49 | 56.19 | 55.91 | 32.14 | 29.59 | 40.51 | 35.18 |
| Unsecured loans | 10.52 | 10.92 | 8.91 | 3.49 | 4.09 | 8.44 | 13.51 |
| Total debt | 54.01 | 67.11 | 64.82 | 35.63 | 33.68 | 48.95 | 48.69 |
| Total liabilities | 128 | 144 | 141 | 100 | 91.55 | 100 | 99.04 |
| Assets | |||||||
| Gross block | 138 | 142 | 129 | 108 | 103 | 96.36 | 90.67 |
| Net block | 85.85 | 94.09 | 87.15 | 70.43 | 69.97 | 69.80 | 69.98 |
| Capital work in progress | 1.77 | 0.09 | 5.66 | 0.01 | 1.75 | 0.01 | 0.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | 1.20 | 0.24 |
| Inventories | 18.74 | 16.74 | 12.67 | 12.46 | 9.93 | 11.26 | 22.43 |
| Sundry debtors | 43.69 | 48.50 | 47.27 | 35.51 | 22.00 | 27.79 | 28.63 |
| Cash & bank balances | 2.32 | 3.08 | 3.59 | 3.37 | 3.23 | 7.77 | 4.83 |
| Loans & advances | 6.94 | 3.07 | 4.37 | 2.06 | 2.01 | 4.56 | 7.21 |
| Total current assets | 71.69 | 71.39 | 67.90 | 53.40 | 37.17 | 51.38 | 63.10 |
| Total current liabilities | 25.64 | 13.04 | 10.98 | 18.05 | 13.82 | 18.01 | 29.85 |
| Net working capital | 46.05 | 58.35 | 56.92 | 35.35 | 23.35 | 33.37 | 33.25 |
| Total assets | 128 | 144 | 141 | 100 | 91.55 | 100 | 99.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.02 | 0.05 | 0.02 | 0.03 | 0.05 | 1.16 | 0.98 |
| Net cash from operating activities | 22.15 | 11.54 | (14.35) | 7.13 | 21.89 | 16.63 | 4.18 |
| Net cash from investing activities | (2.85) | (7.70) | (10.62) | (3.40) | (3.35) | (11.33) | (2.46) |
| Net cash from financing activities | (19.26) | (3.87) | 25.00 | (3.75) | (18.56) | (6.42) | (1.54) |
| Net change in cash | 0.04 | (0.03) | 0.04 | (0.02) | (0.01) | (1.12) | 0.18 |
| Closing cash | 2.32 | 3.08 | 3.59 | 3.37 | 3.23 | 7.77 | 4.83 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.2% | -7.0% | -19.8% | -3.9% | +29.5% | +28.2% | - |
| EBITDA growth | -63.0% | +177.5% | -77.9% | +8.4% | +189.6% | +191.5% | - |
| PBT growth | - | +9998.0% | - | +2.0% | +2631.4% | +9998.0% | - |
| Net income growth | +1337.0% | +113.9% | -128.1% | +2.5% | +2071.0% | +108.0% | - |
| Revenue CAGR (3Y) | -7.8% | -10.5% | -0.1% | +16.8% | +12.9% | -0.1% | -13.7% |
| EBITDA CAGR (3Y) | -39.0% | -12.7% | -11.5% | - | +12.6% | -25.2% | - |
| Profitability & leverage | |||||||
| Net income margin | -6.1% | +0.2% | -2.4% | +6.2% | +5.8% | +0.3% | -6.0% |
| Return on capital employed | - | +5.6% | +2.6% | +15.0% | +14.1% | +5.9% | +2.1% |
| Return on net worth | - | +0.5% | -3.7% | +12.6% | +14.0% | +0.7% | -8.9% |
| Debt / equity | - | 1.13 | 0.85 | 0.61 | 0.84 | 1.07 | 1.10 |
| Long-term debt / equity | - | 0.32 | 0.23 | 0.17 | 0.25 | 0.28 | 0.22 |
| Interest cover | -299.03 | 117.45 | -319.34 | 33.93 | 30.35 | 13,275.00 | -54.09 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.70 | 0.83 | 1.09 | 1.20 | 0.99 | 0.82 |
| Inventory turnover | - | 5.67 | 7.14 | 9.99 | 10.98 | 5.34 | 3.75 |
| Debtors turnover | - | 1.74 | 2.17 | 3.89 | 4.67 | 3.19 | 2.00 |
| EPS (₹) | (5.17) | 0.20 | (2.06) | 6.80 | 6.61 | 0.27 | (4.06) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 55.51 | 55.40 | 57.32 | 50.56 | 44.01 | 43.72 |
To see the full year-wise statements and ratios of Sunil Healthcare Limited, buy the company report.
Board of directors of Sunil Healthcare Limited
Sunil Healthcare has 8 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Khaitan Also directs: Nada Vibronics Private Limited | Managing Director | 01 Aug 2007 | 19 Years 3 Months | Current |
| Bejon Kumar Misra | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
| Rakesh Mohan Also directs: Akg Exim Limited, Navi Mumbai Smart City Infrastructure Limited | Director | 11 Nov 2016 | 10 Years 0 Months | Current |
| Sanjay Kumar Kaushik Also directs: Kaneeka Trimurti Minerals Private Limited | Director | 03 Jun 2003 | 23 Years 5 Months | Current |
| Harish Pal Kumar Also directs: SK Biz Adviser LLP, Paramount Communications Limited, Ioux Systems Private Limited and 1 more | Director | 13 Feb 2019 | 7 Years 8 Months | Current |
| Mudita Chaturvedi Also directs: Morris Street Advisors Private Limited | Director | 01 Nov 2019 | 7 Years 0 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Sunil Healthcare Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunil Healthcare Limitedthis company | ₹87.72 Cr (FY 2026) | ₹4.1 Cr | 4.7% | 5.2% | New Delhi, Delhi, India | |
| Angstrom Biotech Private Limited | ₹86.9 Cr (FY 2022) | -2.0% | Vadodara, Gujarat, India | |||
| Adeshwar Meditex Limited | ₹83.97 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Beacon Diagnostics Pvt Ltd | ₹82.21 Cr (FY 2025) | -1.0% | Navsari, Gujarat, India | |||
| Erawat Pharma Limited | ₹78.37 Cr (FY 2025) | 14.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Sunil Healthcare Limited, buy the company report.
Auditor
Sunil Healthcare Limited is audited by SINGHI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGHI & CO | FY 2023 | 302049E |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 73.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.10% and retail and other public shareholders hold 26.40%.
Sep 2026
QUARTER
73.50% Promoters
0.10% DII (Domestic Institutional)
26.40% Retail & Others
Promoter holding - history
Now 73.50% · Sep 2026High 73.50% · Dec 2025Low 73.50% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 73.50% | 73.50% | 73.50% | 73.50% |
| Public | 26.50% | 26.50% | 26.50% | 26.50% |
Charges & borrowings
Open charges
₹80.27 Cr
Satisfied charges
₹101.82 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2025 | 101124677 | Others | ₹27.75 Lakh | Open | |
| 31 Dec 2024 | 101056357 | Others | ₹1.22 Cr | Open | |
| 12 Jun 2024 | 100938094 | Yes Bank Limited | ₹1.97 Cr | Open | |
| 15 Feb 2024 | 100880462 | Others | ₹32.9 Lakh | Open | |
| 12 Jan 2024 | 100845299 | Others | ₹32.9 Lakh | Open |
To see the full charge records of Sunil Healthcare Limited, buy the company report.
Total charge records: 44 View all charges
Deals & funding
Sunil Healthcare Limited has 3 deals on record (3 market trades); the latest was in May 2024.
Total deals
3
Market trades
3
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2024 | Market trade | ₹62.3 Lakh | Buyer: an individual |
| Dec 2015 | Market trade | ₹47.2 Lakh | Seller: Qoppa Trading Private Limited |
| Sep 2015 | Market trade | ₹2.66 Cr | Buyer: an individual Seller: Esquire Engineering Ltd |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sunil Healthcare Limited has 103 court cases on record: 58 filed by Sunil Healthcare, 45 filed against it. 25 cases are pending and 78 are disposed.
Total cases
103
Filed by the company
58
Filed against the company
45
Pending
25
Disposed
78
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 50 | 14 | 14 |
| District courts | 48 | 28 | 10 |
| Supreme Court | 4 | 2 | 1 |
| NCLAT | 1 | 1 | 0 |
Cases on record (5 of 103)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Commercial suit | Filed against the company by Nippon Express India Private Limited | Pending |
| High Court of Delhi | Appeal | Filed by the company against M/S Hellmann Worldwide Logistics India Private Limited | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against Rajasthan State Industrial Development and Investment Corporation Limited (Riico) and 1 other | Pending |
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against Rajasthan State Industrial Development and Investment Corporation Limited (Riico) | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against Bisista Pharma Private Limited and Anr | Pending |
To see the full case history of Sunil Healthcare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sunil Healthcare Limited was last rated by Care on 01 Jul 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 01 Jul 2022 |
To see the full credit ratings and regulatory alerts of Sunil Healthcare Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunil Healthcare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunil Healthcare has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCS9198Q1ZA | Delhi | Active | 01 Jul 2017 |
| 08AACCS9198Q1Z8 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sunil Healthcare Limited, buy the company report.
Recent activity
Sunil Healthcare Limited has 19 board changes on record since 2003: 8 appointments and 11 cessations. The latest: Jai Prakash Singh was appointed as Director on 13 Feb 2025.
Charges
A charge with State Bank Of India of Rs. 54.26 Cr registered on 27 Jun 2017 with Charge ID 100112046 was modified on 18 Aug 2026.
Charges
A charge registered on 08 Jul 2016 via Charge ID 100052285 with Others was fully satisfied on 01 Jul 2026.
Filing
Sunil Healthcare Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
AGM
Sunil Healthcare Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge registered on 08 Mar 2019 via Charge ID 100257498 with Others was fully satisfied on 11 Aug 2025.
Charges
A charge with Others amounted to Rs. 0.28 Cr with Charge ID 101124677 was registered on 23 Jun 2025.
Appointed
Jai Prakash Singh was appointed as Director.
Charges
A charge registered on 06 May 2022 via Charge ID 100578282 with Others was fully satisfied on 16 Jan 2025.
Charges
A charge with Others amounted to Rs. 1.22 Cr with Charge ID 101056357 was registered on 31 Dec 2024.
Charges
A charge with Yes Bank Limited amounted to Rs. 1.97 Cr with Charge ID 100938094 was registered on 12 Jun 2024.
Charges
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100880462 was registered on 15 Feb 2024.
Charges
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100845299 was registered on 12 Jan 2024.
94 earlier events are in the company report.
News
Frequently asked questions
Sunil Healthcare is an active public limited company based in New Delhi, Delhi, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 05 February 1973 (53+ years old) and is registered under CIN L24302DL1973PLC189662. Listed on BSE: 537253 and NSE: SUNLOC.
Sunil Healthcare reported revenue of ₹87.72 Cr for FY 2025-26 (up 5.2% YoY) based on consolidated financials.
Sunil Healthcare has 8 current directors:
- Anil Kumar Khaitan - Managing Director
- Bejon Kumar Misra - Director
- Rakesh Mohan - Director
- Sanjay Kumar Kaushik - Director
- Harish Pal Kumar - Director
- Mudita Chaturvedi - Director
- Jai Prakash Singh - Director
- Krishna Venkatachalam Rajan - Director
The latest financial statements of Sunil Healthcare on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sunil Healthcare is 07AACCS9198Q1ZA, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 08AACCS9198Q1Z8 (Rajasthan).
The CIN (Corporate Identification Number) of Sunil Healthcare is L24302DL1973PLC189662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Sunil Healthcare is a listed company as per MCA records. Its shares are listed on both BSE (code: 537253) and NSE (symbol: SUNLOC).
Sunil Healthcare has 103 court cases on record: 58 filed by the company and 45 filed against it. 25 are pending. Most are in the high courts.
Sunil Healthcare was incorporated on 05 February 1973, making it 53+ years old. It is registered with the Registrar of Companies, Delhi.
Sunil Healthcare has 3 deals on record (3 market trades); the latest was in May 2024.
The peers of Sunil Healthcare by revenue are Angstrom Biotech Private Limited, Adeshwar Meditex Limited, Beacon Diagnostics Pvt Ltd, Erawat Pharma Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages